Review



dna cdna transcription kit  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    Thermo Fisher dna cdna transcription kit
    Nucleolar-targeting compounds inhibit nucleolar activity and induce selective <t>DNA</t> damage. ( A ) Representative images of EU incorporation (green) in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control and were stained with DAPI (blue) and Pol II (yellow). ( B ) Mean nucleolar EU intensity per nucleus as a readout for rDNA <t>transcription</t> in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control. The graph depicts one representative biological replicate ( n = 3), with data points representing individual cells, and the median indicated by the red line. A Kruskal–Wallis test was applied to assess differences between groups for the replicates combined, and statistical significance is indicated by numerical P -values. ( C ) Representative images of nuclear 53BP1 and γH2AX foci accumulation in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control, and stained with DAPI (blue), 53BP1 (yellow), and γH2AX (red). ( D ) Fold change of nuclear 53BP1 foci per cell relative to DMSO. Individual points in the graph represent biological replicates ( n = 3). The graph depicts the mean ± SD and statistical significance was assessed by one sample t test and indicated by numerical P -values. ( E ) Fold change of nuclear γH2AX foci per cell relative to DMSO otherwise as in panel (D).
    Dna Cdna Transcription Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 100470 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dna cdna transcription kit/product/Thermo Fisher
    Average 98 stars, based on 100470 article reviews
    dna cdna transcription kit - by Bioz Stars, 2026-02
    98/100 stars

    Images

    1) Product Images from "Ribosome biogenesis is increased in hepatocellular carcinoma and represents a potential therapeutic target"

    Article Title: Ribosome biogenesis is increased in hepatocellular carcinoma and represents a potential therapeutic target

    Journal: NAR Cancer

    doi: 10.1093/narcan/zcaf058

    Nucleolar-targeting compounds inhibit nucleolar activity and induce selective DNA damage. ( A ) Representative images of EU incorporation (green) in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control and were stained with DAPI (blue) and Pol II (yellow). ( B ) Mean nucleolar EU intensity per nucleus as a readout for rDNA transcription in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control. The graph depicts one representative biological replicate ( n = 3), with data points representing individual cells, and the median indicated by the red line. A Kruskal–Wallis test was applied to assess differences between groups for the replicates combined, and statistical significance is indicated by numerical P -values. ( C ) Representative images of nuclear 53BP1 and γH2AX foci accumulation in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control, and stained with DAPI (blue), 53BP1 (yellow), and γH2AX (red). ( D ) Fold change of nuclear 53BP1 foci per cell relative to DMSO. Individual points in the graph represent biological replicates ( n = 3). The graph depicts the mean ± SD and statistical significance was assessed by one sample t test and indicated by numerical P -values. ( E ) Fold change of nuclear γH2AX foci per cell relative to DMSO otherwise as in panel (D).
    Figure Legend Snippet: Nucleolar-targeting compounds inhibit nucleolar activity and induce selective DNA damage. ( A ) Representative images of EU incorporation (green) in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control and were stained with DAPI (blue) and Pol II (yellow). ( B ) Mean nucleolar EU intensity per nucleus as a readout for rDNA transcription in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control. The graph depicts one representative biological replicate ( n = 3), with data points representing individual cells, and the median indicated by the red line. A Kruskal–Wallis test was applied to assess differences between groups for the replicates combined, and statistical significance is indicated by numerical P -values. ( C ) Representative images of nuclear 53BP1 and γH2AX foci accumulation in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control, and stained with DAPI (blue), 53BP1 (yellow), and γH2AX (red). ( D ) Fold change of nuclear 53BP1 foci per cell relative to DMSO. Individual points in the graph represent biological replicates ( n = 3). The graph depicts the mean ± SD and statistical significance was assessed by one sample t test and indicated by numerical P -values. ( E ) Fold change of nuclear γH2AX foci per cell relative to DMSO otherwise as in panel (D).

    Techniques Used: Activity Assay, Control, Staining



    Similar Products

    98
    Thermo Fisher dna cdna transcription kit
    Nucleolar-targeting compounds inhibit nucleolar activity and induce selective <t>DNA</t> damage. ( A ) Representative images of EU incorporation (green) in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control and were stained with DAPI (blue) and Pol II (yellow). ( B ) Mean nucleolar EU intensity per nucleus as a readout for rDNA <t>transcription</t> in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control. The graph depicts one representative biological replicate ( n = 3), with data points representing individual cells, and the median indicated by the red line. A Kruskal–Wallis test was applied to assess differences between groups for the replicates combined, and statistical significance is indicated by numerical P -values. ( C ) Representative images of nuclear 53BP1 and γH2AX foci accumulation in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control, and stained with DAPI (blue), 53BP1 (yellow), and γH2AX (red). ( D ) Fold change of nuclear 53BP1 foci per cell relative to DMSO. Individual points in the graph represent biological replicates ( n = 3). The graph depicts the mean ± SD and statistical significance was assessed by one sample t test and indicated by numerical P -values. ( E ) Fold change of nuclear γH2AX foci per cell relative to DMSO otherwise as in panel (D).
    Dna Cdna Transcription Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dna cdna transcription kit/product/Thermo Fisher
    Average 98 stars, based on 1 article reviews
    dna cdna transcription kit - by Bioz Stars, 2026-02
    98/100 stars
      Buy from Supplier

    98
    Thermo Fisher dna cdna reverse transcription kit
    Nucleolar-targeting compounds inhibit nucleolar activity and induce selective <t>DNA</t> damage. ( A ) Representative images of EU incorporation (green) in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control and were stained with DAPI (blue) and Pol II (yellow). ( B ) Mean nucleolar EU intensity per nucleus as a readout for rDNA <t>transcription</t> in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control. The graph depicts one representative biological replicate ( n = 3), with data points representing individual cells, and the median indicated by the red line. A Kruskal–Wallis test was applied to assess differences between groups for the replicates combined, and statistical significance is indicated by numerical P -values. ( C ) Representative images of nuclear 53BP1 and γH2AX foci accumulation in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control, and stained with DAPI (blue), 53BP1 (yellow), and γH2AX (red). ( D ) Fold change of nuclear 53BP1 foci per cell relative to DMSO. Individual points in the graph represent biological replicates ( n = 3). The graph depicts the mean ± SD and statistical significance was assessed by one sample t test and indicated by numerical P -values. ( E ) Fold change of nuclear γH2AX foci per cell relative to DMSO otherwise as in panel (D).
    Dna Cdna Reverse Transcription Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dna cdna reverse transcription kit/product/Thermo Fisher
    Average 98 stars, based on 1 article reviews
    dna cdna reverse transcription kit - by Bioz Stars, 2026-02
    98/100 stars
      Buy from Supplier

    99
    Thermo Fisher high capacity complementary dna reverse transcription kit
    Nucleolar-targeting compounds inhibit nucleolar activity and induce selective <t>DNA</t> damage. ( A ) Representative images of EU incorporation (green) in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control and were stained with DAPI (blue) and Pol II (yellow). ( B ) Mean nucleolar EU intensity per nucleus as a readout for rDNA <t>transcription</t> in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control. The graph depicts one representative biological replicate ( n = 3), with data points representing individual cells, and the median indicated by the red line. A Kruskal–Wallis test was applied to assess differences between groups for the replicates combined, and statistical significance is indicated by numerical P -values. ( C ) Representative images of nuclear 53BP1 and γH2AX foci accumulation in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control, and stained with DAPI (blue), 53BP1 (yellow), and γH2AX (red). ( D ) Fold change of nuclear 53BP1 foci per cell relative to DMSO. Individual points in the graph represent biological replicates ( n = 3). The graph depicts the mean ± SD and statistical significance was assessed by one sample t test and indicated by numerical P -values. ( E ) Fold change of nuclear γH2AX foci per cell relative to DMSO otherwise as in panel (D).
    High Capacity Complementary Dna Reverse Transcription Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high capacity complementary dna reverse transcription kit/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    high capacity complementary dna reverse transcription kit - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher high capacity complementary dna cdna reverse transcription kit
    E–P distances of selected differentially expressed genes show small changes during differentiation from naive to primed mESCs. (A) Cell culture model of naive to primed transition in mESCs. (B) Changes in Nanog <t>transcription</t> levels (% GAPDH transcription) in naive and primed cells measured by qRT-PCR. The graph depicts median ± standard error of the mean ( n = 5 biological replicates). (C) Nanog genomic region for naive and primed cells, showing from top to bottom: <t>DNA</t> oligoFISH and NOVA FISH probes against promoter and selected enhancers, all predicted enhancers, connection of Nanog promoter to its enhancers, H3K27ac ChiP signal (from ), ATAC-seq signal (from ), CTCF binding motifs, and targeted enhancer regions (vertical gray stripes). Functionally validated enhancers are marked by ◆ . (D) Experimental workflow: regions of interest are marked with two-color DNA oligoFISH, the samples are imaged automatically with spinning disk confocal microscopy, FISH spots are detected automatically with subpixel localization accuracy and 3D distances between matched E–P spots are calculated to produce a E–P distance distribution of the population. Scale bar represents 1 μm. (E) 3D distance [μm] distributions between Nanog promoter and its −5, −45, +60, and +105 (putative) enhancers in naive and primed cells. Dashed line and number next to the histogram represent the median distance. The changes between naive and primed cells are not significant ( P > 0.05, two-sided Wilcoxon rank sum test, BH correction). From closest to furthest enhancer: n naive = 916, 1718, 837, 1220; n primed = 1037, 1038, 1362, 701; three biological replicates each. (F) Change in median 3D E–P distance [μm] of genes down- and up-regulated during the naive to primed transition. E–P pairs above the diagonal show increased distances during differentiation, while distance in pairs below the diagonal decreases. Each circle refers to a different enhancer. The test of statistical significance is the same as in panel (E). Functionally validated enhancers are marked by ◆ .
    High Capacity Complementary Dna Cdna Reverse Transcription Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high capacity complementary dna cdna reverse transcription kit/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    high capacity complementary dna cdna reverse transcription kit - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher high capacity complementary dna cdna reverse transcription kits
    E–P distances of selected differentially expressed genes show small changes during differentiation from naive to primed mESCs. (A) Cell culture model of naive to primed transition in mESCs. (B) Changes in Nanog <t>transcription</t> levels (% GAPDH transcription) in naive and primed cells measured by qRT-PCR. The graph depicts median ± standard error of the mean ( n = 5 biological replicates). (C) Nanog genomic region for naive and primed cells, showing from top to bottom: <t>DNA</t> oligoFISH and NOVA FISH probes against promoter and selected enhancers, all predicted enhancers, connection of Nanog promoter to its enhancers, H3K27ac ChiP signal (from ), ATAC-seq signal (from ), CTCF binding motifs, and targeted enhancer regions (vertical gray stripes). Functionally validated enhancers are marked by ◆ . (D) Experimental workflow: regions of interest are marked with two-color DNA oligoFISH, the samples are imaged automatically with spinning disk confocal microscopy, FISH spots are detected automatically with subpixel localization accuracy and 3D distances between matched E–P spots are calculated to produce a E–P distance distribution of the population. Scale bar represents 1 μm. (E) 3D distance [μm] distributions between Nanog promoter and its −5, −45, +60, and +105 (putative) enhancers in naive and primed cells. Dashed line and number next to the histogram represent the median distance. The changes between naive and primed cells are not significant ( P > 0.05, two-sided Wilcoxon rank sum test, BH correction). From closest to furthest enhancer: n naive = 916, 1718, 837, 1220; n primed = 1037, 1038, 1362, 701; three biological replicates each. (F) Change in median 3D E–P distance [μm] of genes down- and up-regulated during the naive to primed transition. E–P pairs above the diagonal show increased distances during differentiation, while distance in pairs below the diagonal decreases. Each circle refers to a different enhancer. The test of statistical significance is the same as in panel (E). Functionally validated enhancers are marked by ◆ .
    High Capacity Complementary Dna Cdna Reverse Transcription Kits, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high capacity complementary dna cdna reverse transcription kits/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    high capacity complementary dna cdna reverse transcription kits - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    Nucleolar-targeting compounds inhibit nucleolar activity and induce selective DNA damage. ( A ) Representative images of EU incorporation (green) in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control and were stained with DAPI (blue) and Pol II (yellow). ( B ) Mean nucleolar EU intensity per nucleus as a readout for rDNA transcription in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control. The graph depicts one representative biological replicate ( n = 3), with data points representing individual cells, and the median indicated by the red line. A Kruskal–Wallis test was applied to assess differences between groups for the replicates combined, and statistical significance is indicated by numerical P -values. ( C ) Representative images of nuclear 53BP1 and γH2AX foci accumulation in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control, and stained with DAPI (blue), 53BP1 (yellow), and γH2AX (red). ( D ) Fold change of nuclear 53BP1 foci per cell relative to DMSO. Individual points in the graph represent biological replicates ( n = 3). The graph depicts the mean ± SD and statistical significance was assessed by one sample t test and indicated by numerical P -values. ( E ) Fold change of nuclear γH2AX foci per cell relative to DMSO otherwise as in panel (D).

    Journal: NAR Cancer

    Article Title: Ribosome biogenesis is increased in hepatocellular carcinoma and represents a potential therapeutic target

    doi: 10.1093/narcan/zcaf058

    Figure Lengend Snippet: Nucleolar-targeting compounds inhibit nucleolar activity and induce selective DNA damage. ( A ) Representative images of EU incorporation (green) in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control and were stained with DAPI (blue) and Pol II (yellow). ( B ) Mean nucleolar EU intensity per nucleus as a readout for rDNA transcription in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control. The graph depicts one representative biological replicate ( n = 3), with data points representing individual cells, and the median indicated by the red line. A Kruskal–Wallis test was applied to assess differences between groups for the replicates combined, and statistical significance is indicated by numerical P -values. ( C ) Representative images of nuclear 53BP1 and γH2AX foci accumulation in THLE-3, PLC/PRF/5, and SNU-449 cells 24 h after treatment with four anti-cancer drugs targeting the nucleolus: CX-5461, BMH-21, Oxaliplatin, and JP-1302, or targeted therapy Sorafenib. Cells were treated with DMSO as control, and stained with DAPI (blue), 53BP1 (yellow), and γH2AX (red). ( D ) Fold change of nuclear 53BP1 foci per cell relative to DMSO. Individual points in the graph represent biological replicates ( n = 3). The graph depicts the mean ± SD and statistical significance was assessed by one sample t test and indicated by numerical P -values. ( E ) Fold change of nuclear γH2AX foci per cell relative to DMSO otherwise as in panel (D).

    Article Snippet: Reverse transcription polymerase chain reaction (RT-PCR) was performed using the complementary DNA (cDNA) transcription kit with random primers (Thermo Fisher #4368814). cDNA was subjected to quantitative PCR (qPCR) using the Applied Biosystems 7500 Fast Real-Time PCR system with Fast SYBR TM Green Master Mix (Applied Biosystems #4385612) for detection.

    Techniques: Activity Assay, Control, Staining

    E–P distances of selected differentially expressed genes show small changes during differentiation from naive to primed mESCs. (A) Cell culture model of naive to primed transition in mESCs. (B) Changes in Nanog transcription levels (% GAPDH transcription) in naive and primed cells measured by qRT-PCR. The graph depicts median ± standard error of the mean ( n = 5 biological replicates). (C) Nanog genomic region for naive and primed cells, showing from top to bottom: DNA oligoFISH and NOVA FISH probes against promoter and selected enhancers, all predicted enhancers, connection of Nanog promoter to its enhancers, H3K27ac ChiP signal (from ), ATAC-seq signal (from ), CTCF binding motifs, and targeted enhancer regions (vertical gray stripes). Functionally validated enhancers are marked by ◆ . (D) Experimental workflow: regions of interest are marked with two-color DNA oligoFISH, the samples are imaged automatically with spinning disk confocal microscopy, FISH spots are detected automatically with subpixel localization accuracy and 3D distances between matched E–P spots are calculated to produce a E–P distance distribution of the population. Scale bar represents 1 μm. (E) 3D distance [μm] distributions between Nanog promoter and its −5, −45, +60, and +105 (putative) enhancers in naive and primed cells. Dashed line and number next to the histogram represent the median distance. The changes between naive and primed cells are not significant ( P > 0.05, two-sided Wilcoxon rank sum test, BH correction). From closest to furthest enhancer: n naive = 916, 1718, 837, 1220; n primed = 1037, 1038, 1362, 701; three biological replicates each. (F) Change in median 3D E–P distance [μm] of genes down- and up-regulated during the naive to primed transition. E–P pairs above the diagonal show increased distances during differentiation, while distance in pairs below the diagonal decreases. Each circle refers to a different enhancer. The test of statistical significance is the same as in panel (E). Functionally validated enhancers are marked by ◆ .

    Journal: Nucleic Acids Research

    Article Title: Nanoscale dynamics of enhancer–promoter interactions during exit from pluripotency

    doi: 10.1093/nar/gkaf1255

    Figure Lengend Snippet: E–P distances of selected differentially expressed genes show small changes during differentiation from naive to primed mESCs. (A) Cell culture model of naive to primed transition in mESCs. (B) Changes in Nanog transcription levels (% GAPDH transcription) in naive and primed cells measured by qRT-PCR. The graph depicts median ± standard error of the mean ( n = 5 biological replicates). (C) Nanog genomic region for naive and primed cells, showing from top to bottom: DNA oligoFISH and NOVA FISH probes against promoter and selected enhancers, all predicted enhancers, connection of Nanog promoter to its enhancers, H3K27ac ChiP signal (from ), ATAC-seq signal (from ), CTCF binding motifs, and targeted enhancer regions (vertical gray stripes). Functionally validated enhancers are marked by ◆ . (D) Experimental workflow: regions of interest are marked with two-color DNA oligoFISH, the samples are imaged automatically with spinning disk confocal microscopy, FISH spots are detected automatically with subpixel localization accuracy and 3D distances between matched E–P spots are calculated to produce a E–P distance distribution of the population. Scale bar represents 1 μm. (E) 3D distance [μm] distributions between Nanog promoter and its −5, −45, +60, and +105 (putative) enhancers in naive and primed cells. Dashed line and number next to the histogram represent the median distance. The changes between naive and primed cells are not significant ( P > 0.05, two-sided Wilcoxon rank sum test, BH correction). From closest to furthest enhancer: n naive = 916, 1718, 837, 1220; n primed = 1037, 1038, 1362, 701; three biological replicates each. (F) Change in median 3D E–P distance [μm] of genes down- and up-regulated during the naive to primed transition. E–P pairs above the diagonal show increased distances during differentiation, while distance in pairs below the diagonal decreases. Each circle refers to a different enhancer. The test of statistical significance is the same as in panel (E). Functionally validated enhancers are marked by ◆ .

    Article Snippet: Total RNA was isolated using NucleoSpin RNA, Mini kit for RNA purification (Marcherey-Nagel) according to the manufacturer’s instructions. cDNA was synthesized using the High-Capacity complementary DNA (cDNA) Reverse Transcription Kit (Applied Biosystems) with 500 ng RNA as input. qRT-PCR with primers ( ) was performed in 10 μl reactions with 5 ng cDNA as input.

    Techniques: Cell Culture, Quantitative RT-PCR, Binding Assay, Confocal Microscopy

    Shorter E–P distances correlate with active transcription. (A) Schematic representation: do enhancer and promoter come closer when the gene is actively transcribed? (B) Genomic location of Nanog intron RNA FISH probes. (C) Experimental workflow: intron RNA is marked by RNA FISH, imaged, promoters and enhancers are marked by DNA FISH, imaged, then RNA and DNA images are aligned using fiducial markers. (D) STED microscopy images (maximum intensity projections) of promoter (magenta), enhancers (yellow), and intron RNA (cyan) for Nanog . Scale bar represents 1 μm. (E) E–P 3D distance [µm] changes significantly based on distance of nascent RNA to P ( P < 0.05: *, P < 0.005: **, two-sided Wilcoxon rank sum test). n ≤0.25 = 46, n ≤0.5 = 156, n ≤1 = 272, n ≤1.5 = 172, n ≤3 = 259 over three biological replicates.

    Journal: Nucleic Acids Research

    Article Title: Nanoscale dynamics of enhancer–promoter interactions during exit from pluripotency

    doi: 10.1093/nar/gkaf1255

    Figure Lengend Snippet: Shorter E–P distances correlate with active transcription. (A) Schematic representation: do enhancer and promoter come closer when the gene is actively transcribed? (B) Genomic location of Nanog intron RNA FISH probes. (C) Experimental workflow: intron RNA is marked by RNA FISH, imaged, promoters and enhancers are marked by DNA FISH, imaged, then RNA and DNA images are aligned using fiducial markers. (D) STED microscopy images (maximum intensity projections) of promoter (magenta), enhancers (yellow), and intron RNA (cyan) for Nanog . Scale bar represents 1 μm. (E) E–P 3D distance [µm] changes significantly based on distance of nascent RNA to P ( P < 0.05: *, P < 0.005: **, two-sided Wilcoxon rank sum test). n ≤0.25 = 46, n ≤0.5 = 156, n ≤1 = 272, n ≤1.5 = 172, n ≤3 = 259 over three biological replicates.

    Article Snippet: Total RNA was isolated using NucleoSpin RNA, Mini kit for RNA purification (Marcherey-Nagel) according to the manufacturer’s instructions. cDNA was synthesized using the High-Capacity complementary DNA (cDNA) Reverse Transcription Kit (Applied Biosystems) with 500 ng RNA as input. qRT-PCR with primers ( ) was performed in 10 μl reactions with 5 ng cDNA as input.

    Techniques: Microscopy